抗原驱动的聚糖特异性"缺乏DH"B细胞的融合进化在葡萄糖合物免疫小鼠中
Sachin Kushwaha1, Pratiksha Shome1, Devinder Sehgal1
1Molecular Immunology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India.
ImmunoHorizons
|August 2, 2024
概括
糖结合物疫苗的增强剂量导致对多糖的抗体反应受到限制,与对载体蛋白的多样性反应不同. 这表明,抗原驱动的选择塑造了抗体谱,影响了疫苗的设计.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
背景情况:
- 葡萄糖结合物疫苗诱导T细胞依赖的抗体对抗多糖的反应.
- 长期免疫力通常需要多剂量免疫,但增强免疫对抗体库的影响尚未完全理解.
研究的目的:
- 调查用模型糖联接疫苗 (肺炎球菌囊多糖类14型与交叉反应物质197结合) 进行增强免疫接种对抗体对多糖和载体蛋白质的作用.
- 为了获得对抗体反应在增强剂后成熟的分子洞察力.
主要方法:
- 针对肺炎球菌囊多糖类14型 (PCP14) 和交叉反应物质197 (CRM197) 产生的小鼠单克隆抗体 (mAbs) 的综合序列分析.
- 用PCP14-CRM197糖合抗原的一剂或三剂免疫小鼠.
- 对配对免疫球蛋白重链和轻链转录的分析.
主要成果:
- 发现抗PCP14抗体谱系受到高度限制,有抗原驱动的选择和抗体序列的融合进化的证据.
- 缺乏DH编码氨基酸的抗体在抗PCP14反应中占主导地位.
- 相比之下,抗CRM197抗体反应具有较少突变的多样性,这表明与载体蛋白特异性抗体发育的干扰.
结论:
- 用糖结合物疫苗进行增强免疫接种会导致对多糖体抗原的抗体数量受到限制.
- 这些发现突显了抗原驱动的选择在塑造抗体对葡萄糖合物疫苗的反应中的作用.
- 这些见解对于优化糖结合物疫苗的设计至关重要,特别是当对载体蛋白的反应也被期望时.
更多相关视频
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
3.4K
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
5.0K
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Antigens Involved in Adaptive Immunity
479
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
479
